Rob Hegele

London, Ontario, Canada

Are triglyceride-rich lipoproteins involved in atherogenesis? Genetics, epidemiology and biology tell the story Triglyceridemia as Risk Factor for CVD

Rob Hegele is Distinguished University Professor of Medicine and Biochemistry, Western University, and director of the Lipid Genetics Clinic and the London Regional Genomics Centre in London, Canada.

He holds the Jacob J. Wolfe Distinguished Medical Research Chair and the Martha Blackburn Chair in Cardiovascular Research. He cares for 2000 patients in his lipid clinic. His lab studies the genetics of lipids, diabetes and heart disease, and has discovered the molecular genetic basis of 20 human diseases. He has published more than 550 papers, which have been cited more than 15,000 times in the medical literature. He has contributed to recent international treatment guidelines for hypertriglyceridemia, and to national treatment guidelines for cholesterol, blood pressure and diabetes. He has trained numerous physicians, medical students and graduate students.

Stay up to date, subscribe to the newsletter

Progression and prevention of atherosclerosis and a translation to relevance.